A novel neuroinflammation-responsive hydrogel based on mimicking naked mole rat brain microenvironment retards neurovascular dysfunction and cognitive decline in Alzheimer’s disease-Reference-Cited by-同舟云学术

A novel neuroinflammation-responsive hydrogel based on mimicking naked mole rat brain microenvironment retards neurovascular dysfunction and cognitive decline in Alzheimer’s disease

Published:2022-02 Issue: Volume:430 Page:133090
ISSN:1385-8947
Container-title:Chemical Engineering Journal
language:en
Short-container-title:Chemical Engineering Journal

Author:

Zhao Yufang,Qiao Shupei,Zhang Bosong,Cao Yue,Tian Hui,Liu Runze,Sun Liuke,Wang Cao,Li Liang,Wang Ruiqi,Chen Yue,Hou Xiaolu,Li Yongming,Zhou Jin,Li Liyi,Tian Weiming

Funder

National Natural Science Foundation of China

China Postdoctoral Science Foundation

Heilongjiang Postdoctoral Science Foundation

Publisher

Elsevier BV

Subject

Industrial and Manufacturing Engineering,General Chemical Engineering,Environmental Chemistry,General Chemistry

Reference55 articles.

1. Neuroinflammation and microglial activation in alzheimer disease: where do we go from here?;Leng;Nat. Rev. Neurol.,2021

2. Overcoming barriers to early disease intervention;Caicedo;Nat. Biotechnol.,2020

3. Inflammation and Alzheimer's disease;Akiyama;Neurobiol. Aging.,2000

4. Complement and microglia mediate early synapse loss in alzheimer mouse models;Hong;Science.,2016

5. Inflammatory responses to amyloidosis in a transgenic mouse model of alzheimer's disease;Matsuoka;Am. J. Pathol.,2001

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In-silico structural analysis of Heterocephalus glaber amyloid beta: an anti-Alzheimer's peptide;MOL BIOL RES COMMUN;2024

2. Macromolecular nanoparticles to attenuate both reactive oxygen species and inflammatory damage for treating Alzheimer's disease;Bioengineering & Translational Medicine;2022-11-29

3. Particle Hydrogels Decrease Cerebral Atrophy and Attenuate Astrocyte and Microglia/Macrophage Reactivity after Stroke;Advanced Therapeutics;2022-06-28